China's medical products administrator granted MGI Tech (SHA:688114) subsidiary Qingdao MGI Intelligent Manufacturing Technology medical device approval for its gene sequencer, according to a Tuesday filing with the Shanghai Stock Exchange.
The gene sequencer is used in human DNA samples to help with the diagnosis of diseases, the filing said.
Shares rose 2% during Tuesday's late morning trading.